The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma

Pediatric Neurosurgery

Volumn 39, Issue 2, 2003, Pages 68-74

  Chopra, Arun ^a   Brown, Kevin M ^a,b   Rood, Brian R ^a   Packer, Roger J ^a   MacDonald, Tobey J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Gene expression; Medulloblastoma; Metastasis; Microarray; Signaling

Indexed keywords

BETA TUBULIN; BIOLOGICAL FACTOR; COLLAGEN TYPE 6; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBRONECTIN; FK 506 BINDING PROTEIN; MESSENGER RNA; MUTATED IN ADVANCED CANCER PROTEIN; ONCOPROTEIN; OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN MYCC; PROTEIN P15; PROTEIN TYROSINE KINASE; RECEPTOR SUBUNIT; RNA POLYMERASE II ELONGATION FACTOR SIII; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN METASTASIS; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC REGULATION; GENETIC STRAIN; HUMAN; MEDULLOBLASTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CEREBELLAR NEOPLASMS; CHILD; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR II; MEDULLOBLASTOMA; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROSPECTIVE STUDIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037971940     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071317     Document Type: Article

References (22)

1. Packer RJ, Cogen P, Vezina G, Rorke LB: Medulloblastoma: Clinical and biologic aspects. Neuro-oncol 1999;1:232-250.
2. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17:832-845.
3. Johnson DL, McCabe MA, Nicholson HS, Joseph AL, Getson PR, Byrne J, Brasseux C, Packer RJ, Reaman G: Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994;80:1004-1010.
4. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM: Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study. J Clin Oncol 2001;19:3470-3476.
5. MacDonald TJ, Brown K, LaFleur B, Peterson K, Lawlor C, Chen Y, Packer RJ, Cogen P, Stephan DA: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001;29:143-152.
6. Hernan R, Fasheh R, Calabrese C, Frank AJ, Maclean KH, Allard D, Barraclough R, Gilbertson RJ: ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res 2003;63:140-148.
7. Gilbertson RJ, Pearson AD, Perry RH, Jaros E, Kelly PJ: Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. Br J Cancer 1995;71:473-477.
8. Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC: MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 2001;7:2425-2433.
9. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 1994;91:12867-12871.
10. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-442.
11. Werner H, Le Roith D: New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia. Cell Mol Life Sci 2000;57:932-942.
12. Lazar-Molnar E, Hegyesi H, Toth S, Falus A: Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000;12:547-554.
13. LeBedis C, Chen K, Fallavollita L, Boutros T, Brodt P: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002;100:2-8.
14. Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: From basic to clinical studies and clinical applications. Oncology 2002;63:317-332.
15. Andrae J, Molander C, Smits C, Funa K, Nister M: Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells. Biochem Biophys Res Commun 2002;296:604-611.
16. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995;81:727-736.
17. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA, Jove R: Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 2001;98:7319-7324.
18. Furstoss O, Dorsey K, Simon V, Barila D, Superti-Furga G, Roche S: c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J 2002;21:514-524.
19. Chiariello M, Marinissen MJ, Gutkind JS: Regulation of c-myc expression by PDGF through Rho GTPases. Nat Cell Biol 2001;3:580-586.
20. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihile J, Cleveland JL: c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002;16:2530-2543.
21. Valafar F: Pattern recognition techniques in microarray data analysis: A survey. Ann NY Acad Sci 2002;980:41-64.
22. Takai-Igarashi T, Kaminuma T: A pathway finding system for the cell signaling networks database. In Silico Biol 1999;1:129-146.